Technical Articles

The ongoing global public health crisis triggered by SARS-CoV-2 has propelled international academic and industrial communities to intensify efforts in elucidating the fundamental biological properties of the novel coronavirus, as well as accelerating the development of preventive vaccines and therapeutic interventions. Within this context, research focused on antigen-specific T cells has emerged as a pivotal frontier in immunology. This field not only provides critical immunological response indicators for vaccine development but also holds substantial scientific significance across multiple domains, including disease prognosis monitoring, deciphering viral infection mechanisms, and advancing cancer immunotherapy strategies.